CellOrigin Unveils Two Novel Solid-Tumor Cell Therapy Candidates at ASCO 2026, Partners with Walvax for In Vivo CAR Clinical Trial
HANGZHOU, China, July 31, 2026 /PRNewswire/ -- CellOrigin, a biotechnology company focused on next-generation in vivo and in vitro cell therapy technologies, has announced two major progresses in both research and strategic partnership. At the 2026...
MagicLab Robotics Unveils Its Embodied AI Vision in Silicon Valley, Expands Global Reach to 50 Countries
SAN FRANCISCO, April 29, 2026 /PRNewswire/ -- MagicLab Robotics, a global embodied AI pioneer, hosted the Global Embodied Intelligence Summit (GEIS) in Silicon Valley today, unveiling its next-generation product portfolio. The showcase featured the...